SEC Form D · filed May 6, 2021
Gilgamesh Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Dalibor Sames · New York, NYDirectorJonathan Sporn · New York, NYExec · DirectorRobert Berman · New York, NYDirectorAndrew Kruegel · New York, NYExec · DirectorEdward Harycki · Bryn Mawr, PAExec · DirectorGautam Shah · Cedar Park, TXDirectorJulie B. Sanders · Dallas, TXExec · DirectorShawn O'Brien · NOVI, MIDirectorAmy Kruse · Jackson, WYDirectorKent Gordon · Salt Lake City, UTDirectorJames T. Farrell · San Francisco, CAExec · DirectorGaurav Sahni · Short Hills, X1Exec · DirectorChris Wood · Seattle, WADirectorAmy Kruse · Jackson, WYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗